세계의 엑소좀 기술 시장(2025년)

Exosome Technologies Global Market Report 2025

US $ 4,490 ￦ 6,371,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,209,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,048,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 엑소좀 기술 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 시장은 27.8%의 연평균 복합 성장률(CAGR)로 확대되고 2029년에는 2억 4,000만 달러로 성장할 것으로 예측됩니다. 예측기간의 성장은 규제의 진전, 생물의학공학의 혁신, 임상시험의 보급, 재생의료의 개발, 나노기술통합의 성장에 기인할 것으로 예상됩니다. 예측 기간의 주요 동향으로는 치료 진보, 진단, 나노기술 통합, 연구 자금 급증, 분리 기술 개발 등이 있습니다.

엑소좀 기술시장의 성장이 예상되는 배경에는 만성질환의 유병률 상승이 있습니다. 만성 질환은 3개월 이상 지속되는 지속적 또는 장기적인 영향을 특징으로 하여 엑소좀 기술에 대한 수요를 창출하고 있습니다. 이러한 기술은 질병 특이적 바이오마커의 확인, 엑소좀 카고 분석에 의한 질병 진행의 모니터링, 표적 약물 전달의 촉진, 만성 질환에서의 면역조절에 중요한 역할을 합니다. 예를 들어, 2023년 1월 통계에 따르면 미국에서는 50세 이상에서 하나 이상의 만성 질환을 가진 사람의 수가 99.5% 증가했으며, 2020년 7,152만 2,000명에서 2050년에는 1억 4,266만명에 이를 것으로 예측됩니다. 호주에서는 2022년 7월 호주 보건복지연구소(AIHW)가 발표한 바에 따르면 인구의 47%, 1,160만 명이 10가지 만성 질환 중 적어도 하나를 앓고 있는 것으로 추정됩니다. 따라서 만성질환의 유병률 증가는 엑소좀 기술시장의 성장을 가속할 것으로 예상됩니다.

헬스케어 지출 증가는 향후 수년간 엑소좀 기술 시장의 성장을 가속할 것으로 예상됩니다. 헬스케어 지출은 특정 헬스케어 시스템 또는 경제에서 정해진 기간 동안 헬스케어 서비스, 물품, 활동에 할당된 총 자금을 나타냅니다. 이 지출 증가는 연구개발을 지원하고 임상적 응용을 위한 상환을 가능하게 하고 만성질환 관리의 노력을 강화하고 인프라를 강화하기 위해 엑소좀 기술을 진보시키는 주요 요인입니다. 예를 들어, 2022년 12월 미국에 본사를 둔 Centers for Medicare & Medicaid Services는 미국 헬스케어 지출이 4.1% 증가한 4조 5,000억 달러에 이르렀고 2021년 3.2% 증가에서 상승했다고 보고했습니다. 그 결과, 헬스케어 지출 증가가 엑소좀 기술 시장의 확대에 박차를 가하고 있습니다.

본 보고서는 세계의 엑소좀 기술 시장에 대해 조사했으며, 시장 개요와 함께 엑소좀 유형별, 세포원별, 용도별, 최종 사용자별, 지역·국가별 동향 및 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 엑소좀 기술 시장 특징

제3장 엑소좀 기술 시장 동향과 전략

제4장 엑소좀 기술 시장 - 금리, 인플레이션, 지정학, 코로나연과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계 엑소좀 기술의 성장 분석과 전략 분석 프레임워크

• PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업의 분석
• 성장률 분석
• 시장 규모 실적과 성장, 2019-2024년
• 시장 규모와 성장 예측, 2024-2029년, 2034년 예상
• 획득 가능한 최대 시장 규모(TAM)

제6장 엑소좀 기술 시장 세분화

• 세계의 엑소좀 기술 시장, 엑소좀 유형별 세분화, 분석 및 예측, 2019-2024년, 2024-2029년 예측, 2034년 예측
• 세계의 엑소좀 기술 시장, 세포원별 세분화, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 엑소좀 기술 시장, 용도별 세분화, 분석 및 예측, 2019-2024년, 2024-2029년 예측, 2034년 예측
• 세계의 엑소좀 기술 시장, 최종 사용자별 세분화, 분석 및 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 엑소좀 기술 시장, 카고 탑재의 서브 세분화, 유형별, 분석 및 예측, 2019-2024년, 2024-2029년 예측, 2034년 예측
• 세계의 엑소좀 기술 시장, 카고 비탑재의 서브 세분화, 유형별, 분석 및 예측, 2019-2024년, 2024-2029년 예측, 2034년 예측

제7장 엑소좀 기술시장의 지역 및 국가별 분석

• 세계의 엑소좀 기술 시장, 지역별, 분석 및 예측, 2019-2024년, 2024-2029년 예측, 2034년 예측
• 세계의 엑소좀 기술 시장, 국가별, 분석 및 예측, 2019-2024년, 2024-2029년 예측, 2034년 예측

제8장 아시아태평양의 엑소좀 기술 시장

제9장 중국의 엑소좀 기술 시장

제10장 인도의 엑소좀 기술 시장

제11장 일본의 엑소좀 기술 시장

제12장 호주 엑소좀 기술 시장

제13장 인도네시아의 엑소좀 기술 시장

제14장 한국의 엑소좀 기술시장

제15장 서유럽의 엑소좀 기술 시장

제16장 영국의 엑소좀 기술 시장

제17장 독일의 엑소좀 기술 시장

제18장 프랑스의 엑소좀 기술 시장

제19장 이탈리아의 엑소좀 기술 시장

제20장 스페인의 엑소좀 기술 시장

제21장 동유럽의 엑소좀 기술시장

제22장 러시아 엑소좀 기술시장

제23장 북미의 엑소좀 기술시장

제24장 미국의 엑소좀 기술 시장

제25장 캐나다의 엑소좀 기술 시장

제26장 남미의 엑소좀 기술시장

제27장 브라질의 엑소좀 기술 시장

제28장 중동의 엑소좀 기술시장

제29장 아프리카의 엑소좀 기술 시장

제30장 엑소좀 기술 시장 경쟁 구도와 기업 프로파일

• 엑소좀 기술시장 경쟁 구도
• 엑소좀 기술 시장 기업 프로파일
  • AEGLE Therapeutics
  • Aruna Bio Inc.
  • Carmine Therapeutics Inc.
  • Exosome Diagnostics Inc.
  • Creative Biolabs Inc.

제31장 엑소좀 기술시장 기타 대형 및 혁신적 기업

• Danaher Corporation
• OmniSpirant Limited
• Thermo Fisher Scientific Inc.
• Fujifilm Holdings Corporation
• Anjarium Biosciences
• NOVADIP Biosciences SA
• Exopharm Ltd.
• Organicell Regenerative Medicine Inc.
• Evox Therapeutics
• Direct Biologics
• ExoCan Healthcare Technologies Pvt. Ltd.
• ExoCoBio
• ExonanoRNA LLC
• ILIAS Biologics Inc.
• Illumina Inc.

제32장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 동향

제35장 잠재성이 높은 국가, 부문, 전략

제36장 부록

JHS

영문 목차

영문목차

Exosome technologies involve the utilization of exosomes, which are small extracellular vesicles originating from endosomes, across diverse fields such as regenerative medicine, biotechnology, and biomedical research. This technology holds promise for applications in diagnostics, especially in liquid biopsy-based diagnostics and projects focused on discovering biomarkers. Exosomes, due to their unique characteristics, can serve as diagnostic biomarkers for the early identification of diseases.

Two primary types of exosome technologies are loaded cargo and non-cargo. Loaded cargo pertains to exosomes that have been modified to carry specific cargos, including therapeutic agents, employing passive or active loading methods. These engineered exosomes are derived from various cell sources such as HEK293 cells, mesenchymal stem cells (MSCs), platelets, erythrocytes, natural killer cells, and others. They find applications in both therapeutics and diagnostics, with end-users encompassing healthcare providers, pharmaceutical and biotechnology companies, and other entities.

The exosome technologies market research report is one of a series of new reports from The Business Research Company that provides exosome technologies market statistics, including exosome technologies industry global market size, regional shares, competitors with an exosome technologies market share, detailed exosome technologies market segments, market trends and opportunities, and any further data you may need to thrive in the exosome technologies industry. This exosome technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The exosome technologies market size has grown exponentially in recent years. It will grow from$0.07 billion in 2024 to $0.09 billion in 2025 at a compound annual growth rate (CAGR) of 26.3%. The growth in the historic period can be attributed to therapeutic advancements, isolation technique developments, research funding boosts, regenerative medicine exploration, and clinical trials inception

The exosome technologies market size is expected to see exponential growth in the next few years. It will grow to$0.24 billion in 2029 at a compound annual growth rate (CAGR) of 27.8%. The growth in the forecast period can be attributed to regulatory progress, biomedical engineering innovations, clinical trials proliferation, regenerative medicine development, and nanotechnology integration growth. Major trends in the forecast period include therapeutic advancements, diagnostic applications, nanotechnology integration, research funding surge, and the development of isolation techniques.

The anticipated growth in the exosome technologies market is driven by the increasing prevalence of chronic diseases. Chronic diseases, characterized by persistent or long-lasting effects lasting three months or more, are on the rise, creating a demand for exosome technologies. These technologies play a crucial role in identifying disease-specific biomarkers, monitoring disease progression through exosome cargo analysis, facilitating targeted drug delivery, and immune modulation in chronic conditions. For instance, statistics from January 2023 indicate that the number of individuals aged 50 years and older with one or more chronic illnesses in the United States is projected to increase by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020. In Australia, an estimated 47% of the population, or 11.6 million individuals, are affected by at least one of the ten selected chronic ailments, as reported by the Australian Institute of Health and Welfare (AIHW) in July 2022. Hence, the escalating prevalence of chronic diseases is expected to drive the growth of the exosome technologies market.

Increasing healthcare expenditure is expected to drive the growth of the exosome technologies market in the coming years. Healthcare expenditure represents the total funds allocated to healthcare services, goods, and activities within a specific healthcare system or economy over a defined period. This rising expenditure is a key factor in advancing exosome technologies, as it supports research and development, enables reimbursement for clinical applications, bolsters chronic disease management efforts, and enhances infrastructure. For example, in December 2022, the U.S.-based Centers for Medicare & Medicaid Services reported that U.S. healthcare spending grew by 4.1% to reach $4.5 trillion, a rise from the 3.2% increase in 2021. Consequently, growing healthcare spending is fueling the expansion of the exosome technologies market.

The exosome technology market is witnessing a prominent trend in the adoption of advanced exosome characterization technologies. Companies within this market are integrating new technologies to maintain their competitive standing. For example, in August 2022, Creative Biolabs Inc., a biotech company based in the United States, introduced the NanosightTM platform for exosome characterization, leveraging Nanosight technology. Nanosight is a nanoparticle tracking analysis (NTA) technique enabling the visualization and quantification of exosomes based on their size and concentration. By offering this platform, Creative Biolabs intends to equip researchers with sophisticated tools for the comprehensive characterization and analysis of exosomes, facilitating a deeper understanding of their properties and functions.

Major players in the exosome technology sector are embracing a strategic partnership approach, seeking to capitalize on synergies and expedite progress in this dynamically evolving field. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutually beneficial outcomes. In June 2023, RoosterBio Inc., a biotechnology firm based in the United States, forged a partnership with Repligen, a life sciences company focused on bioprocessing. This collaboration aims to accelerate the development of scalable and cost-effective exosome bioprocessing solutions, ultimately enhancing accessibility to exosome-based therapies for patients.

In August 2024, BioIVT LLC, a U.S.-based provider of biospecimen solutions, acquired ZenBio Inc. for an undisclosed sum. This acquisition enables BioIVT to strengthen its expertise in cell and tissue models, expanding its portfolio of high-quality biological products for use in research and drug development. ZenBio Inc., also based in the U.S., is a biotechnology company specializing in human exosome research products.

Major companies operating in the exosome technologies market include AEGLE Therapeutics, Aruna Bio Inc., Carmine Therapeutics Inc., Exosome Diagnostics Inc., Creative Biolabs Inc., Danaher Corporation, OmniSpirant Limited, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Anjarium Biosciences, NOVADIP Biosciences S.A., Exopharm Ltd., Organicell Regenerative Medicine Inc., Evox Therapeutics, Direct Biologics, ExoCan Healthcare Technologies Pvt. Ltd., ExoCoBio, ExonanoRNA LLC, ILIAS Biologics Inc., Illumina Inc., Invitrix Therapeutics, XOStem Inc., VivaZome Therapeutics Pty Ltd., Aethlon Medical Inc., Capricor Therapeutics, Codiak BioSciences, Exogenus Therapeutics, Exovita Biosciences, HansaBioMed Life Sciences, Hitachi Chemical Advanced Therapeutics Solutions

North America was the largest region in the exosome technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global exosome technologies market report during the forecast period. The regions covered in the exosome technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The exosome technologies market consists of revenues earned by entities by providing exosome technologies services such as vaccine development, biomarker production, exosome-based diagnostic testing, and therapeutic development. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome technologies market consists of sales of exosome isolation kits, purification reagents, characterization tools, analysis kits, and exosome-based therapeutic products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The exosome technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Exosome Type: Loaded Cargos; Non-Cargo
• 2) By Cell Source: HEK293 Cells; Mesenchymal Stem Cells (MSCs); Platelets; Erythrocytes; Natural Killer Cells; Other Cell Sources
• 3) By Application: Therapeutics; Diagnostics
• 4) By End-Users: Health Care Providers; Pharmaceutical And Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Loaded Cargo: Proteins; Nucleic Acids (DNA, RNA); Lipids; Small Molecules
• 2) By Non-Cargo: Exosome Membrane Components; Extracellular Matrix Components
• Companies Mentioned: AEGLE Therapeutics; Aruna Bio Inc.; Carmine Therapeutics Inc.; Exosome Diagnostics Inc.; Creative Biolabs Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Exosome Technologies Market Characteristics

3. Exosome Technologies Market Trends And Strategies

4. Exosome Technologies Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Exosome Technologies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Exosome Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Exosome Technologies Market Growth Rate Analysis
• 5.4. Global Exosome Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Exosome Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Exosome Technologies Total Addressable Market (TAM)

6. Exosome Technologies Market Segmentation

• 6.1. Global Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Loaded Cargos
• Non-Cargo
• 6.2. Global Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• HEK293 Cells
• Mesenchymal Stem Cells (MSCs)
• Platelets
• Erythrocytes
• Natural Killer Cells
• Other Cell Sources
• 6.3. Global Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Diagnostics
• 6.4. Global Exosome Technologies Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Health Care Providers
• Pharmaceutical And Biotechnology Companies
• Other End-Users
• 6.5. Global Exosome Technologies Market, Sub-Segmentation Of Loaded Cargo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proteins
• Nucleic Acids (DNA, RNA)
• Lipids
• Small Molecules
• 6.6. Global Exosome Technologies Market, Sub-Segmentation Of Non-Cargo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exosome Membrane Components
• Extracellular Matrix Components

7. Exosome Technologies Market Regional And Country Analysis

• 7.1. Global Exosome Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Exosome Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exosome Technologies Market

• 8.1. Asia-Pacific Exosome Technologies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exosome Technologies Market

• 9.1. China Exosome Technologies Market Overview
• 9.2. China Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exosome Technologies Market

• 10.1. India Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exosome Technologies Market

• 11.1. Japan Exosome Technologies Market Overview
• 11.2. Japan Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exosome Technologies Market

• 12.1. Australia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exosome Technologies Market

• 13.1. Indonesia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exosome Technologies Market

• 14.1. South Korea Exosome Technologies Market Overview
• 14.2. South Korea Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exosome Technologies Market

• 15.1. Western Europe Exosome Technologies Market Overview
• 15.2. Western Europe Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exosome Technologies Market

• 16.1. UK Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exosome Technologies Market

• 17.1. Germany Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exosome Technologies Market

• 18.1. France Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exosome Technologies Market

• 19.1. Italy Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exosome Technologies Market

• 20.1. Spain Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exosome Technologies Market

• 21.1. Eastern Europe Exosome Technologies Market Overview
• 21.2. Eastern Europe Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exosome Technologies Market

• 22.1. Russia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exosome Technologies Market

• 23.1. North America Exosome Technologies Market Overview
• 23.2. North America Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exosome Technologies Market

• 24.1. USA Exosome Technologies Market Overview
• 24.2. USA Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exosome Technologies Market

• 25.1. Canada Exosome Technologies Market Overview
• 25.2. Canada Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exosome Technologies Market

• 26.1. South America Exosome Technologies Market Overview
• 26.2. South America Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exosome Technologies Market

• 27.1. Brazil Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exosome Technologies Market

• 28.1. Middle East Exosome Technologies Market Overview
• 28.2. Middle East Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exosome Technologies Market

• 29.1. Africa Exosome Technologies Market Overview
• 29.2. Africa Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exosome Technologies Market Competitive Landscape And Company Profiles

• 30.1. Exosome Technologies Market Competitive Landscape
• 30.2. Exosome Technologies Market Company Profiles
  • 30.2.1. AEGLE Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aruna Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Carmine Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Exosome Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Creative Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Exosome Technologies Market Other Major And Innovative Companies

• 31.1. Danaher Corporation
• 31.2. OmniSpirant Limited
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. Fujifilm Holdings Corporation
• 31.5. Anjarium Biosciences
• 31.6. NOVADIP Biosciences S.A.
• 31.7. Exopharm Ltd.
• 31.8. Organicell Regenerative Medicine Inc.
• 31.9. Evox Therapeutics
• 31.10. Direct Biologics
• 31.11. ExoCan Healthcare Technologies Pvt. Ltd.
• 31.12. ExoCoBio
• 31.13. ExonanoRNA LLC
• 31.14. ILIAS Biologics Inc.
• 31.15. Illumina Inc.

32. Global Exosome Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exosome Technologies Market

34. Recent Developments In The Exosome Technologies Market

35. Exosome Technologies Market High Potential Countries, Segments and Strategies

• 35.1 Exosome Technologies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Exosome Technologies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Exosome Technologies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료